Greg Zante, Chief Financial Officer at Viking Therapeutics, Inc. (VKTX), sold 21,217 shares at $33.47 ($710K) on 2026-07-29, disclosed to the SEC on 2026-07-29.
Open-market sale of $710k VKTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.1M | — | Filing → |
| VKTX | SELL | 2024-10-28 | $19.7M | — | Filing → |